JMPWA
EBS icon

JP Morgan Private Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,774
Closed -$365K – 1936
2022
Q2 		$365K Sell
11,774
-874
-7% -$29.8K ﹤0.01% 1567
2022
Q1 		$519K Sell
12,648
-2,321
-16% -$102K ﹤0.01% 1519
2021
Q4 		$651K Sell
14,969
-43,335
-74% -$1.96M ﹤0.01% 1443
2021
Q3 		$2.92M Sell
58,304
-866
-1% -$52.4K 0.01% 750
2021
Q2 		$3.73M Sell
59,170
-956
-2% -$61.4K 0.01% 664
2021
Q1 		$5.59M Buy
60,126
+2,525
+4% +$259K 0.02% 484
2020
Q4 		$5.16M Buy
57,601
+4,636
+9% +$425K 0.02% 469
2020
Q3 		$5.47M Buy
52,965
+778
+1% +$83.9K 0.02% 410
2020
Q2 		$4.13M Buy
52,187
+10,951
+27% +$816K 0.02% 401
2020
Q1 		$2.39M Buy
41,236
+27,505
+200% +$1.59M 0.01% 502
2019
Q4 		$741K Sell
13,731
-2,283
-14% -$124K ﹤0.01% 902
2019
Q3 		$837K Buy
16,014
+5,249
+49% +$245K ﹤0.01% 824
2019
Q2 		$520K Sell
10,765
-319
-3% -$15.3K ﹤0.01% 968
2019
Q1 		$560K Sell
11,084
-1,364
-11% -$80.5K ﹤0.01% 983
2018
Q4 		$738K Sell
12,448
-809
-6% -$52.2K ﹤0.01% 847
2018
Q3 		$873K Buy
13,257
+1,257
+10% +$73.3K ﹤0.01% 867
2018
Q2 		$606K Buy
12,000
+2,576
+27% +$134K ﹤0.01% 945
2018
Q1 		$496K Buy
9,424
+374
+4% +$18.6K ﹤0.01% 875
2017
Q4 		$421K Buy
9,050
+187
+2% +$7.87K ﹤0.01% 932
2017
Q3 		$359K Buy
8,863
+1,296
+17% +$46.9K ﹤0.01% 969
2017
Q2 		$257K Buy
7,567
+563
+8% +$17.4K ﹤0.01% 1068
2017
Q1 		$203K Buy
+7,004
New +$213K ﹤0.01% 1239

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

JP Morgan Private Wealth Advisors's EBS Position: Q3 2022 in Review

JP Morgan Private Wealth Advisors sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 11,774 shares — an estimated $365K sold.

JP Morgan Private Wealth Advisors first reported a position in EBS in Q1 2017 and held it in 22 quarters. The position peaked at $5.59M in Q1 2021. 210 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 11,774 Emergent Biosolutions shares in Q3 2022, an estimated $365K.
  • JP Morgan Private Wealth Advisors first reported a position in Emergent Biosolutions in Q1 2017 and held it in 22 quarters.
  • JP Morgan Private Wealth Advisors's Emergent Biosolutions position peaked at $5.59M in Q1 2021.
  • 210 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.